Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2007, Vol. 109, No. 3, pp. 1165-1173.
Prepublished online as a Blood First Edition Paper on October 12, 2006; DOI 10.1182/blood-2006-05-015354.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-05-015354v1
109/3/1165    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vremec, D.
Right arrow Articles by Shortman, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vremec, D.
Right arrow Articles by Shortman, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted May 16, 2006
Accepted August 30, 2006

Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells and interferon-producing killer dendritic cells

David Vremec, Meredith O'Keeffe, Hubertus Hochrein, Martina Fuchsberger, Irina Caminschi, Mireille Lahoud, and Ken Shortman*

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
Bavarian Nordic GmbH, Munich, Germany

* Corresponding author; email: shortman{at}wehi.edu.au.

The capacity of mouse spleen conventional dendritic cells (cDC) and plasmacytoid dendritic cells (pDC) to produce interferon (IFN)-{gamma} or IFN-{alpha} was assessed, and compared to that of natural killer (NK) cells and the recently identified interferon-producing killer dendritic cells (IKDC), both of which are frequent contaminants in DC preparations. Fully developed cDC or pDC, if free of NK cells or IKDC, showed little capacity for IFN-{gamma} production. However an early developmental form of the CD4-8+ cDC subtype, and the Ly6C- Ly49Q- pDC subtype, both were able to produce moderate amounts of IFN-{gamma}, although less than IKDC. In response to toll-like receptor 9 stimuli both the Ly6C+ Ly49Q+ and the Ly6C- Ly49Q- pDC subtypes were effective producers of IFN-{alpha}. However IKDC, which efficiently produced IFN-{gamma} and showed immediate cytotoxicity on NK target cells, did not produce IFN-{alpha} under these conditions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020